Sign Up for Our Newsletter
Contact Donate

Anaplastic Large Cell Lymphoma

Program Status

Fully Allocated – We are no longer accepting or processing applications for new or renewal patients.

Maximum Award Level

$15,000 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

Patient should be insured and insurance must cover the medication for which patient seeks assistance.
The medication must treat the disease directly.
Patient must reside and receive treatment in the United States.
Patient’s income must fall below 500% of the Federal Poverty Level.

Get Help With Your Treatment

Apply Online (Click Here) or call 1-866-316-PANF (7263)

Information About the Disease

Anaplastic Large Cell Lymphoma (ALCL) is a relatively uncommon type of non-Hodgkin’s lymphoma (NHL) that arises from T-cells. Most individuals with ALCL first complain of enlarged lymph nodes though it rarely affects the intestines or the bone without involving lymph nodes. ALCL affects both children and adults. In adults, it is a relatively rare lymphoma, but in children ALCL accounts for 1 in 10 cases of all lymphomas.

For more information visit the Leukemia and Lymphoma Society website.